avelumab   Click here for help

GtoPdb Ligand ID: 8735

Synonyms: Bavencio® | MSB-0010718C | MSB0010718C
Approved drug Immunopharmacology Ligand
avelumab is an approved drug (EMA & FDA (2017))
Compound class: Antibody
Comment: Avelumab is a programmed death-ligand 1 (PD-L1; CD274) blocking human IgG1 lambda monoclonal antibody . It is the first drug approved for the treatment of Merkel cell carcinoma (MCC).
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record.
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (EMA & FDA (2017))
International Nonproprietary Names Click here for help
INN number INN
10062 avelumab
Synonyms Click here for help
Bavencio® | MSB-0010718C | MSB0010718C
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 512
Other databases
GtoPdb PubChem SID 252827393
Search PubMed clinical trials avelumab
Search PubMed titles avelumab
Search PubMed titles/abstracts avelumab